SCHEMBL26487709

SCHEMBL26487709

CN[C@H](C)c1cccc(Cl)c1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 1/20 0.45
HTR2A P28223 8/20 0.43
SLC6A4 P31645 8/20 0.43
KCNH2 Q12809 6/20 0.43
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
NFKB1 P19838 1/20 0.41
PNMT P11086 1/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
GLA P06280 1/20 0.40
SCN1A P35498 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN8A Q9UQD0 1/20 0.38
SOS1 Q07889 1/20 0.35
ADRB1 P08588 2/20 0.35
ADRB2 P07550 1/20 0.35
PPARG P37231 1/20 0.35
ADRA2A P08913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25628064 0.83 CFD (0.44) CFDCYP2D6CYP1A2CYP3A4NFKB1
SCHEMBL25632944 0.80 CFD (0.45) CFDHTR2ASLC6A4KCNH2CYP2D6
SCHEMBL17553263 0.80 CFD (0.47) CFDCYP2D6CYP1A2CYP3A4NFKB1
SCHEMBL2668988 0.80 CES2 (0.41) HTR2ASLC6A4KCNH2CYP2D6SOS1
SCHEMBL8284240 0.80 CYP2D6 (0.59) HTR2ASLC6A4KCNH2CYP2D6CYP1A2
SCHEMBL26948996 0.80 CES2 (0.41) HTR2ASLC6A4KCNH2CYP2D6SOS1
SCHEMBL2400753 0.79 HTR2A (0.51) HTR2ASLC6A4KCNH2CYP2D6CYP1A2
SCHEMBL15983857 0.79 HTR2A (0.51) HTR2ASLC6A4KCNH2CYP2D6CYP1A2
SCHEMBL15983778 0.79 HTR2A (0.51) HTR2ASLC6A4KCNH2CYP2D6CYP1A2
SCHEMBL8216990 0.79 CFD (0.50) CFDCYP2D6CYP1A2CYP3A4NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067546-A1 NOVEL BICYCLIC HETEROARYL DERIVATIVES AS SOS1:KRAS PROTEINPROTEIN INTERACTION INHIBITORS SATYARX PHARMA INNOVATIONS PVT LTD (IN) 2023-04-27 WO disclosed